Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FHNP1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $19,804.80 for 200-unit vials of BOTOX on a firm fixed-price basis. The award was issued on November 10, 2025, with an ultimate completion date of December 3, 2025. This delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which was awarded on November 13, 2025. The underlying IDC carries a ceiling value of $499.999 billion and an ultimate completion date of December 31, 2036, positioning the contractor as a critical pharmaceutical supplier for Department of Defense military healthcare facilities worldwide. The PPV-G GEN V initiative is part of a broader $30.3 billion acquisition strategy designed to provide a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables to support recurring medical supply needs across the global military medical system.
Quick answers
Who was awarded contract SPE2DR26FHNP1?
SPE2DR26FHNP1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FHNP1 worth?
The government has obligated $19,805 on SPE2DR26FHNP1.
Is contract SPE2DR26FHNP1 an order under another contract?
Yes. SPE2DR26FHNP1 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNP1 competed?
The extent of competition for SPE2DR26FHNP1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award